Carmen Klein Herenbrink

Author

Monash University ORCID

Also Known As

Carmen Klein Herenbrink, Klein Herenbrink, Carmen

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Monash University Columbia University New York Psychoanalytic Society and Institute National Institutes of Health National Institute on Drug Abuse

About

Carmen Klein Herenbrink is an author at Monash University specializing in dopamine research, neuropharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	117
2	Molecular Biology	2	2	117
3	Neuroscience	2	2	117
4	Natural Sciences	1	1	86
5	Biochemistry	1	1	86

Carmen Klein Herenbrink

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
The role of kinetic context in apparent biased agonism at GPCRs Carmen Klein Herenbrink, David A. Sykes, Prashant Donthamsetti, Nature Communications	2016	330
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief Dane D. Jensen, TinaMarie Lieu, Michelle L. Halls, Science Translational Medicine	2017	236
Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission Rebecca Yarwood, Wendy L. Imlach, TinaMarie Lieu, Proceedings of the National Academy of Sciences	2017	180
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome Nestor N. Jiménez-Vargas, Luke A. Pattison, Peishen Zhao, Proceedings of the National Academy of Sciences	2018	175
A Structure–Activity Analysis of Biased Agonism at the Dopamine D2 Receptor Jeremy Shonberg, Carmen Klein Herenbrink, Laura López, Journal of Medicinal Chemistry Biased AgonismDrug TargetNeurotransmitterMolecular BiologyPharmacotherapy	2013	86
Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D <sub>2</sub> Receptor Mónika Szabó, Carmen Klein Herenbrink, Arthur Christopoulos, Journal of Medicinal Chemistry	2014	68
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D <sub>2</sub> Receptor Through Fragmentation of a Bitopic Ligand Shailesh N. Mistry, Jeremy Shonberg, Christopher J. Draper-Joyce, Journal of Medicinal Chemistry	2015	51
A Novel Nonribose Agonist, LUF5834, Engages Residues That Are Distinct from Those of Adenosine-Like Ligands to Activate the Adenosine A2a Receptor J. Robert Lane, Carmen Klein Herenbrink, Gerard J. P. van Westen, Molecular Pharmacology	2011	42
Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors Carmen Klein Herenbrink, Jonatan Fullerton Støier, William Dalseg Reith, Communications Biology	2022	36
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D 2 receptor Christopher J. Draper-Joyce, Mayako Michino, Ravi Kumar Verma, Biochemical Pharmacology Signal TransductionDopamine D 2Functional SelectivityStructural DeterminantsMedicine	2018	31

Page 1